Stockscreener 앱 받기
30.34
2.95%
0.87
전일 마감가:
$29.47
열려 있는:
$29.31
하루 거래량:
2.06M
Relative Volume:
1.69
시가총액:
$2.90B
수익:
$305.00K
순이익/손실:
$-328.98M
주가수익비율:
-7.1134
EPS:
-4.2652
순현금흐름:
$-309.60M
1주 성능:
+5.46%
1개월 성능:
+26.31%
6개월 성능:
+122.11%
1년 성능:
+54.64%
1일 변동 폭
$29.00
$30.77
1주일 범위
$28.33
$30.77
52주 변동 폭
$9.90
$30.77
Viridian Therapeutics Inc Stock (VRDN) Company Profile
명칭
Viridian Therapeutics Inc
전화
617.272.4600
주소
221 CRESCENT STREET, WALTHAM
VRDN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRDN
Viridian Therapeutics Inc
|
30.34 | 2.81B | 305.00K | -328.98M | -309.60M | -4.2652 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 재개 | Jefferies | Buy |
| 2024-12-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-11-25 | 개시 | TD Cowen | Buy |
| 2024-09-11 | 재확인 | Needham | Buy |
| 2024-06-11 | 개시 | Wolfe Research | Outperform |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-05-09 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2023-06-14 | 개시 | BTIG Research | Buy |
| 2023-06-14 | 재개 | Credit Suisse | Outperform |
| 2023-05-30 | 개시 | RBC Capital Mkts | Outperform |
| 2023-04-17 | 개시 | Wells Fargo | Overweight |
| 2023-03-30 | 개시 | Stifel | Buy |
| 2022-12-19 | 개시 | Cowen | Outperform |
| 2022-12-19 | 개시 | Needham | Buy |
| 2022-12-16 | 개시 | Credit Suisse | Outperform |
| 2022-12-01 | 개시 | H.C. Wainwright | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-11-18 | 개시 | SVB Leerink | Outperform |
| 2021-10-12 | 개시 | Evercore ISI | Outperform |
| 2021-01-25 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Viridian Therapeutics Inc 주식(VRDN)의 최신 뉴스
Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 39% Price Boost Is Out Of Tune With Revenues - simplywall.st
Viridian Therapeutics stock hits 52-week high at $30.15 By Investing.com - Investing.com Nigeria
Viridian Therapeutics stock hits 52-week high at $30.15 - Investing.com India
Discipline and Rules-Based Execution in VRDN Response - news.stocktradersdaily.com
Is Viridian Therapeutics Inc. stock attractive for hedge fundsDollar Strength & Stepwise Entry and Exit Trade Signals - newser.com
Is Viridian Therapeutics Inc. stock cheap at current valuation2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
How Viridian Therapeutics Inc. (1S1) stock compares with top peersJuly 2025 Action & Verified Swing Trading Watchlist - newser.com
Is Viridian Therapeutics Inc. stock attractive for growth ETFsJuly 2025 WrapUp & Daily Volume Surge Trade Alerts - newser.com
Will Viridian Therapeutics Inc. stock benefit from sector rotationQuarterly Portfolio Summary & Weekly High Return Stock Opportunities - newser.com
Why Viridian Therapeutics Inc. (1S1) stock is favored by hedge fundsQuarterly Portfolio Review & High Return Trade Guides - newser.com
Will Viridian Therapeutics Inc. stock remain a Wall Street favoriteMarket Rally & High Yield Equity Trading Tips - newser.com
Will Viridian Therapeutics Inc. stock keep outperforming rivals2025 Trade Ideas & High Win Rate Trade Tips - newser.com
Viridian Therapeutics at Jefferies Conference: Strategic TED and FcRn Developments - Investing.com Canada
Regression analysis insights on Viridian Therapeutics Inc. performance2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
Can machine learning forecast Viridian Therapeutics Inc. recoveryWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com
How Viridian Therapeutics Inc. stock performs in interest rate cycles2025 Price Targets & Breakout Confirmation Trade Signals - newser.com
How buybacks impact Viridian Therapeutics Inc. stock valueJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com
4DMT Appoints Kristian Humer as Chief Financial Officer - GlobeNewswire Inc.
RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results - Finviz
Trend analysis for Viridian Therapeutics Inc. this weekWeekly Trade Review & Safe Entry Momentum Stock Tips - newser.com
Can swing trading help recover from Viridian Therapeutics Inc. lossesWeekly Stock Report & Precise Buy Zone Identification - newser.com
Why Viridian Therapeutics Inc. (1S1) stock is a must watch tickerForecast Cut & AI Based Buy and Sell Signals - newser.com
Viridian Therapeutics stock hits 52-week high at $29.27 By Investing.com - Investing.com Canada
Will Viridian Therapeutics Inc. (1S1) stock attract long term capital inflows2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Using Ichimoku Cloud for Viridian Therapeutics Inc. technicals2025 Market Overview & Technical Confirmation Alerts - newser.com
Viridian Therapeutics stock hits 52-week high at $29.27 - Investing.com India
Viridian Therapeutics Inc (VRDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):